Your session is about to expire
← Back to Search
Web-based Sleep Interventions for Caregiver Insomnia (NiteCAPP Trial)
NiteCAPP Trial Summary
This trial is testing whether a web-based sleep intervention will help rural caregivers of people with dementia, by improving sleep, arousal, stress, inflammation, and related health concerns.
NiteCAPP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NiteCAPP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had trouble sleeping for over 6 months, affecting my daily life.I am over 18, live with someone who has dementia, can read English, have insomnia, and haven't used sleep meds recently or have used them consistently for 6+ months.
- Group 1: NiteCAPP CARES
- Group 2: NiteCAPP SHARES
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any openings left for this research endeavor?
"Per the clinicaltrials.gov records, this research study seeks to make enrolments and was initially made available on February 2nd 2022 with its most recent update happening at the end of October in 2022."
What effects are researchers hoping to observe by the end of this clinical trial?
"This clinical trial will evaluate the efficacy of pain relief and a possible improvement in quality of life through single blood draws at baseline, 8 weeks, 6 months and 12 follow up time frames. Secondary outcomes to be measured include Internet Intervention Utility Questionnaire (IIUQ) scores ranging from 0-65, Dementia Patient's Caregiver Quality of Life Scale questionnaires with 20 items measuring CG's QOLs, as well as changes in depression severity via Beck Depression Inventory-II scored on a scale between 0 to 63."
How many participants have enrolled in this clinical trial?
"Affirmative. According to clinicaltrials.gov, this medical examination is still enrolling patients and was originally listed on February 2nd 2022. The study aims to find 100 participants from 1 center."
Share this study with friends
Copy Link
Messenger